Literature DB >> 7739512

Outbreak of Ebola viral hemorrhagic fever--Zaire, 1995.

.   

Abstract

On May 6, 1995, CDC was notified by health authorities and the U.S. Embassy in Zaire of an outbreak of viral hemorrhagic fever (VHF)-like illness in Kikwit, Zaire (1995 population: 400,000), a city located 240 miles east of Kinshasa. The World Health Organization and CDC were invited by the Government of Zaire to participate in an investigation of the outbreak. This report summarizes preliminary findings from this ongoing investigation.

Entities:  

Mesh：

Year:  1995        PMID： 7739512

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  14 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

Authors:  Jeffrey E Lee; Ana Kuehne; Dafna M Abelson; Marnie L Fusco; Mary Kate Hart; Erica Ollmann Saphire
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

3.  Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases.

Authors:  C L Fritz; D T Dennis; M A Tipple; G L Campbell; C R McCance; D J Gubler
Journal:  Emerg Infect Dis       Date:  1996 Jan-Mar       Impact factor: 6.883

4.  Inflammatory responses in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; A J Georges; M-C Georges-Courbot; M Capron; I Bedjabaga; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut.

Authors:  M D Kluger; A N Sofair; C J Heye; J I Meek; R K Sodhi; J L Hadler
Journal:  Am J Public Health       Date:  2001-08       Impact factor: 9.308

6.  Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.

Authors:  V N Malashkevich; B J Schneider; M L McNally; M A Milhollen; J X Pang; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.

Authors:  Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Incubation period of ebola hemorrhagic virus subtype zaire.

Authors:  Martin Eichner; Scott F Dowell; Nina Firese
Journal:  Osong Public Health Res Perspect       Date:  2011-04-12

9.  Global health security and the International Health Regulations.

Authors:  Jon Kim Andrus; Ximena Aguilera; Otavio Oliva; Sylvain Aldighieri
Journal:  BMC Public Health       Date:  2010-12-03       Impact factor: 3.295

10.  Ebola and Its Global Research Architecture--Need for an Improvement.

Authors:  David Quarcoo; Dörthe Brüggmann; Doris Klingelhöfer; David A Groneberg
Journal:  PLoS Negl Trop Dis       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.